AR is a steroid hormone receptor frequently expressed in BC, including the ER-negative subtypes for which it could represent a complementary target for therapy, though the clinical significance and functional role of AR has not been outlined in BC yet [40,41]. This evidence concerns the gene ESR1 and breast cancer.